2018 was a huge year for the cannabis industry.
The state of California — the fifth-largest economy in the world — officially began the legal sales of adult-use cannabis.
The entire country of Canada officially legalized adult-use cannabis.
Mexico began the process of ending the prohibition of cannabis.
All across the world, new legalization legislation was introduced, debated, and passed.
Make no mistake: The momentum behind the legalization of cannabis is a global one, and 2018 really served as the launching pad.
Cannabis investors certainly made a fortune in 2018, too.
And some of those who jumped in a few years ago — on my recommendation, and in anticipation of what we knew would happen in 2018 — became millionaires.
Of course, that’s not hard to do when Canadian cannabis stocks such as Canopy Growth Corporation (TSX: WEED), Aphria, Inc. (TSX: APH), and OrganiGram (TSX-V: OGI) all delivered gains in excess of 1,000%.
That being said, those stocks are now “old news.”
The big money has already been made in the Canadian sector, but the U.S. sector is just now starting to really heat up.
The U.S. cannabis market in 2019 is like the Canadian cannabis market of 2016.
Momentum is building, massive amounts of capital are moving in, and the political landscape is changing in a way that will ultimately lead to the full-scale legalization of cannabis — on a federal level.
While individual states have been the catalyst for momentum in the U.S., in 2019, we’re going to see — for the first time — a real push for legalization on the federal level.
This is the result of a number of things, including:
The firing of Attorney General Jeff Sessions, who was one of the most outspoken prohibitionists in Washington.
The replacement of Representative Pete Sessions, who was the former chairman of the House Rules Committee and the person who decided which bills made it to the House floor. Pete Sessions continually did everything in his power to keep any legalization bill from getting to the floor, where it could be properly debated and voted on. But with Sessions gone, there’s now a long list of legalization-related bills that will finally be given a fair hearing.
As a matter of observation, Democrats tend to be more in favor of legalization than Republicans. And with the Democrats now running the House, expect to see more legalization bills introduced — and many with bipartisan support.
A new wave of legalization momentum began in 2018 in a number of key states, including New York, Illinois, New Mexico, New Jersey, and Connecticut. If these five states are successful at initiating some kind of adult-use cannabis legalization in 2019, it would put more pressure on the federal government to lift the prohibition on cannabis.
Cannabis: The Millionaire-Maker
Now that legalization is in place in Canada, members of my Green Chip Stocks community have taken their massive winnings off the table and have begun to re-allocate that capital into the U.S. market.
While there’s still plenty of money to be made in the Canadian cannabis space, you’re simply just going to get more bang for your buck in the U.S. cannabis market in 2019. And that’s where we’re now focused.
Some of the U.S. cannabis stocks that we expect to absolutely crush it in 2019 include, but are not limited to:
- Innovative Industrial Properties (NYSE: IIPR)
- Curaleaf Holdings (OTCBB: CURLF)
- Liberty Health Sciences (OTCBB: LHSIF)
- iAnthus (OTCBB: ITHUF)
- MariMed (OTCBB: MRMD)
- Acreage Holdings (OTCBB: ACRZF)
And in addition to the U.S., there are other opportunities outside of North America.
Elixinol (OTCBB: ELLXF) has some pretty nice exposure to Australia, and Khiron Life Sciences (OTCBB: KHRNF) is a good choice in Latin America. The latter is quite impressive, boasting the former president of Mexico, Vicente Fox, on its board.
Of course, the cannabis industry has been rapidly evolving over the past few years, and 2019 will be no different.
So if you’re looking to capitalize on this continued growth, I strongly urge you to become a member of Green Chip Stocks, where I send out weekly updates on the cannabis industry, as well as new stock picks.
You can also learn how I uncovered some of my biggest winners in the space by clicking here.
Some of those big winners that we closed out in 2018 include:
- Aphria, Inc. (TSX: APH) — 1,174.3% gain
- OrganiGram (TSX-V: OGI) — 1,185% gain
- Canopy Growth Corporation (TSX: WEED) — 3,015.6% gain
Members of my community who invested just $25K in Canopy Growth Corporation when I first made the recommendation turned that initial investment into nearly $800,000.
Double up to $50K, and that was an easy $1.5 million.
From one stock!
That ain’t chump change.
And make no mistake: What we already did in Canada cannabis stocks, we’re about to do again in U.S. cannabis stocks.
Click here to join us now.
To a new way of life and a new generation of wealth...
@JeffSiegel on Twitter
Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.